NO874193L - Farmasoeytiske preparater. - Google Patents

Farmasoeytiske preparater. Download PDF

Info

Publication number
NO874193L
NO874193L NO874193A NO874193A NO874193L NO 874193 L NO874193 L NO 874193L NO 874193 A NO874193 A NO 874193A NO 874193 A NO874193 A NO 874193A NO 874193 L NO874193 L NO 874193L
Authority
NO
Norway
Prior art keywords
stated
approx
resorption
antibiotic
fatty acid
Prior art date
Application number
NO874193A
Other languages
English (en)
Norwegian (no)
Other versions
NO874193D0 (no
Inventor
Joel Unowsky
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO874193D0 publication Critical patent/NO874193D0/no
Publication of NO874193L publication Critical patent/NO874193L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO874193A 1986-10-07 1987-10-06 Farmasoeytiske preparater. NO874193L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91615086A 1986-10-07 1986-10-07

Publications (2)

Publication Number Publication Date
NO874193D0 NO874193D0 (no) 1987-10-06
NO874193L true NO874193L (no) 1988-04-08

Family

ID=25436780

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874193A NO874193L (no) 1986-10-07 1987-10-06 Farmasoeytiske preparater.

Country Status (14)

Country Link
EP (1) EP0263493A3 (da)
JP (1) JPS6396138A (da)
CN (1) CN87106855A (da)
AU (1) AU7939487A (da)
DK (1) DK521487A (da)
FI (1) FI874382L (da)
HU (1) HU196903B (da)
IE (1) IE872667L (da)
IL (1) IL84099A0 (da)
MC (1) MC1878A1 (da)
NO (1) NO874193L (da)
PT (1) PT85871B (da)
ZA (1) ZA876930B (da)
ZW (1) ZW18787A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0643315B2 (ja) * 1988-01-20 1994-06-08 東京田辺製薬株式会社 胆汁酸組成物
DD293494A5 (de) * 1989-03-29 1991-09-05 Fahlberg List Gmbh Magdeburg Verfahren zur herstellung einer galenischen zubereitung mit optimaler bioverfuegbarkeit des wirkstoffs 2-hydroxy-5-methyllauro-phenonoxim (hmlo)
CA2033714A1 (en) * 1990-01-25 1991-07-26 Alberto Ferro Pharmaceutical preparations
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
CA2744697C (en) * 2008-11-26 2016-06-21 Satiogen Pharmaceuticals, Inc. Use of compositions comprising bile acids, salts, and mimics thereof for the treatment of obesity or diabetes
WO2010062861A2 (en) 2008-11-26 2010-06-03 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of obesity and diabetes
ES2552657T3 (es) 2010-05-26 2015-12-01 Satiogen Pharmaceuticals, Inc. Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias
US20130108573A1 (en) 2011-10-28 2013-05-02 Lumena Pharmaceuticals, Inc. Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
AU2012328526B2 (en) 2011-10-28 2017-05-25 Shire Human Genetic Therapies, Inc. Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
CN105617353A (zh) * 2016-01-04 2016-06-01 李志海 一种黏菌素口服给药组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form

Also Published As

Publication number Publication date
DK521487A (da) 1988-04-08
PT85871B (en) 1990-01-17
FI874382A0 (fi) 1987-10-06
HU196903B (en) 1989-02-28
CN87106855A (zh) 1988-04-20
EP0263493A2 (de) 1988-04-13
FI874382A7 (fi) 1988-04-08
JPS6396138A (ja) 1988-04-27
AU7939487A (en) 1988-04-14
IE872667L (en) 1988-04-07
PT85871A (en) 1987-11-01
MC1878A1 (fr) 1989-01-24
DK521487D0 (da) 1987-10-05
IL84099A0 (en) 1988-03-31
HUT45395A (en) 1988-07-28
ZW18787A1 (en) 1988-05-25
NO874193D0 (no) 1987-10-06
EP0263493A3 (de) 1989-06-14
ZA876930B (en) 1988-05-25
FI874382L (fi) 1988-04-08

Similar Documents

Publication Publication Date Title
US12527807B2 (en) Drug composition containing abiraterone acetate, and preparation method therefor and application thereof
US5190748A (en) Absorption enhancement of antibiotics
EP0721330B1 (en) Pharmaceutical composition
CA1165689A (en) Method of increasing oral absorption of polar bioactive agents
NO833757L (no) Oral doseringsform.
NO874193L (no) Farmasoeytiske preparater.
US5952383A (en) Pharmaceutical composition for oral delivery
IL148357A (en) Pharmaceutical preparations containing derivatives of benzamide
KR20040089605A (ko) Ｃ형 간염 바이러스 프로테아제 억제제에 대한 약제학적조성물
NO169155B (no) Fremgangsmaate for fremstilling av ibuprofenholdige kapsler av myk gelatin
BRPI0708965A2 (pt) formulações para liberação parenteral de compostos e usos das mesmas
JPH0249723A (ja) 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
JPH07223967A (ja) 消化器疾患治療薬
CA2152420A1 (en) Therapeutic agent for the treatment of xerostomia
JP2000511885A (ja) 成長ホルモン分泌促進薬による睡眠の強化
JPH0774165B2 (ja) 製剤学的組成物
JP2677613B2 (ja) ビタミンｅ又はその誘導体の吸収促進組成物
TWI834862B (zh) 用於經口投遞滲透性不良蛋白質、肽及小分子之調配物
JP2002525274A (ja) 成長ホルモン分泌促進剤による独立生活状況への復帰促進
NO166569B (no) Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika.
AT392906B (de) Pharmazeutische praeparate zur oralen verabreichung
EP0213552A2 (en) Oily suspension for intrarectal infusion
JPS631923B2 (da)
WO1999056738A1 (en) Use of triclosan for the treatment of helicobacter pylori infections
US20250205264A1 (en) Methods of using avermectin compositions for the treatment of spasticity and dosing regimens